RIDAX
Price
$24.61
Change
-$0.13 (-0.53%)
Updated
Dec 17 closing price
RIEBX
Price
$24.71
Change
-$0.13 (-0.52%)
Updated
Dec 17 closing price
Ad is loading...

RIDAX vs RIEBX

Header iconRIDAX vs RIEBX Comparison
Open Charts RIDAX vs RIEBXBanner chart's image
American Funds Income Fund of Amer R1
Price$24.61
Change-$0.13 (-0.53%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R2E
Price$24.71
Change-$0.13 (-0.52%)
VolumeN/A
CapitalizationN/A
RIDAX vs RIEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RIDAX vs. RIEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RIDAX is a Buy and RIEBX is a Buy.

FUNDAMENTALS
Fundamentals
RIDAX (123B) and RIEBX (123B) have equal amount of cash in the bank . RIEBX pays higher dividends than RIDAX: RIEBX (3.09) vs RIDAX (2.82). RIDAX was incepted earlier than RIEBX: RIDAX (23 years) vs RIEBX (10 years). RIDAX (40.00) and RIEBX (40.00) have comparable annual turnover. RIDAX (250) and RIEBX (250) have matching initial minimum investment requirements. RIEBX (10.29) and RIDAX (10.05) have marching annual gain over last year. RIEBX return over 5 years is better than : 18.40 vs. RIDAX (17.26).
RIDAXRIEBXRIDAX / RIEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD8.7218.96897%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets123B123B100%
Annual Yield % from dividends2.823.0991%
Returns for 1 year10.0510.2998%
Returns for 3 years4.515.1388%
Returns for 5 years17.2618.4094%
Returns for 10 years28.1129.7195%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPK1.610.01
+0.62%
OPKO Health
PFG77.54-1.13
-1.44%
Principal Financial Group
HI30.81-0.69
-2.19%
Hillenbrand
VRA3.88-0.10
-2.51%
Vera Bradley
BTAI0.39-0.02
-4.01%
BioXcel Therapeutics